Role of Sex in the Treatment and Clinical Outcomes of Pediatric Patients With Inflammatory Bowel Disease
- 1 December 2012
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 55 (6), 701-706
- https://doi.org/10.1097/mpg.0b013e318266241b
Abstract
To examine sex differences in medical therapy and clinical outcomes in pediatric patients with inflammatory bowel disease (IBD). We performed a cross-sectional analysis of children with Crohn disease (CD) and ulcerative colitis (UC) using data from the ImproveCareNow Network collected between May 2007 and May 2010. Clinical remission, disease severity, body mass index (BMI) z scores, normal height velocity, and medication use were analyzed by sex and age. One thousand four hundred nine patients were included (993 had CD and 416 had UC). No significant sex differences were found in disease severity, BMI, height velocity, or use of medications. Further analysis of combination therapy with infliximab + 6-mercaptopurine/azathioprine and infliximab + methotrexate also did not reveal any differences. No sex differences were found after mediation use was stratified by age (those younger than 13 years and those 13 years old or older). In this sample of CD and UC pediatric patients, no significant sex differences were found in disease severity, BMI, height velocity, or medication use. Our data do not support the use of sex as a major factor in patient risk stratification for children with IBD. In addition, despite concerns for sex-specific complications of some medications, our analysis did not suggest any sex differences in medication use.This publication has 25 references indexed in Scilit:
- Improved Outcomes in a Quality Improvement Collaborative for Pediatric Inflammatory Bowel DiseasePEDIATRICS, 2012
- Short pediatric Crohnʼs disease activity index for quality improvement and observational researchInflammatory Bowel Diseases, 2011
- Determinants of Changes in Linear Growth and Body Composition in Incident Pediatric Crohn's DiseaseGastroenterology, 2010
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseThe New England Journal of Medicine, 2010
- Top-down therapy for IBD: rationale and requisite evidenceNature Reviews Gastroenterology & Hepatology, 2010
- The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United StatesClinical Gastroenterology and Hepatology, 2007
- Gender differences in body composition deficits at diagnosis in children and adolescents with Crohnʼs diseaseInflammatory Bowel Diseases, 2007
- Relationship between clinical features of Crohn??s disease and the risk of developing extraintestinal manifestationsEuropean Journal of Gastroenterology & Hepatology, 2007
- Risk Factors for Initial Surgery in Pediatric Patients With Crohn’s DiseaseGastroenterology, 2006
- Growth and clinical course of children with Crohn's disease.Gut, 1993